CAPABILITIES CATALOG NEWS AND PUBLICATIONS ABOUT CONTACT US SCROLL CARDIOVASCULAR SYSTEM LEARN MORE CENTRAL NERVOUS SYSTEM LEARN MORE DERMATOLOGY LEARN MORE GASTRO-INTESTINAL SYSTEM LEARN MORE INFLAMMATION LEARN MORE LIVER & HEPATIC SYSTEM LEARN MORE ONCOLOGY LEARN MORE OBESITY & METABOLIC DISORDERS LEARN MORE ❮ ❯ DOWNLOAD PDF Predictive Toxicology November 9, 2021 Predictive Toxicity / Publications Early in vitro predictive toxicology testing can help mitigate major drug development risks. PORSOLT provides in vitro screening that tests for major adverse effects on different organs such as liver, brain, heart, kidney, and skin, using primary rodent, human cells, as well as human iPSC. Below is an example of our 3D iPS neurotoxicity assay, […]... Read more... Models of Lower Back Pain amd Arthritis November 9, 2021 Pain / Publications Porsolt continues to expand, and improve its catalog of models for pain, inflammation and arthritis. This includes a rat model for Lower Back Pain, involving degeneration of the lumbar facet joints induced by intra-articular injection of monosodium iodoacetate (MIA). Evolution of the pain sensation is evaluated by tactile stimulation at the points of injury, and reactions […]... Read more... Employment Opportunities at Porsolt November 9, 2021 News Are you looking for a stimulating, dynamic, and rewarding career in a growing and exciting field? Is being part of a warm and friendly work environment important to you? If the answer to these questions is “YES”, please visit Porsolt’s Careers page to learn more about our different employment opportunities currently on offer. https://lnkd.in/dyK2wnkk... Read more... SEE ALL NEWS AND PUBLICATIONS Porsolt Z.A. de Glatigné 53940 Le Genest-Saint-Isle, France Telephone +33 2 43 69 36 07 LinkedIn Legal Notice Any questions or concerns ? CONTACT US © COPYRIGHT - PORSOLT 2021

CAPABILITIES CATALOG NEWS AND PUBLICATIONS ABOUT CONTACT US About Us Porsolt is an internationally recognized and long established global preclinical Contract Research Organization (CRO) long, that has been providing efficacy evaluation and safety pharmacology services for over 35 years. Porsolt’s capabilities and services cover the drug development process from early screening through regulatory submission, including comprehensive safety evaluation of drug candidates in full compliance with GLP. SCROLL Capabilities Biomarker Assays Cell & Tissue Banks Formulation Analysis Image Processing & Data Analysis Technical Skill Technical Capabilities Porsolt Z.A. de Glatigné 53940 Le Genest-Saint-Isle, France Telephone +33 2 43 69 36 07 LinkedIn Legal Notice Any questions or concerns ? CONTACT US © COPYRIGHT - PORSOLT 2021